Risk factors

Acurx faces Nasdaq delisting risks due to stockholders' equity and bid price deficiencies, though compliance was later regained.

Cash position decreased to $5.3 million while term loan debt increased to $13.4 million. Accumulated deficit expanded to $103.4 million. New risks highlight AI competition and social engineering threats.

Substantial doubt about continuing as a going concern now reflects recurring losses, negative cash flow, and need for additional capital.

Centurion Acquisition Corp. streamlined its tax disclosures by removing speculative excise tax language, and updated potential dilution figures to reflect an equity value of $273,812,500.

Allogene faces capital constraints with cash down to $258.3 million, forcing manufacturing cutbacks and trial adjustments following a Grade 5 serious adverse event in the ALPHA3 trial.

Angel Studios operates with a novel, unproven business model and a history of significant net losses. The company faces heavy risks from unpredictable audience demand, digital piracy, and platform dependencies.

Regulatory scrutiny on 90/10 Rule compliance and new federal laws like OBBBA heavily shape the business risk profile.

Total indebtedness increased significantly to $277.6 million from $185.4 million, while HUD-insured mortgage notes decreased to 58% of mortgage debt.

Atlanticus Holdings added execution risks from the Mercury acquisition and rising inflation impacts on consumer credit. Regulatory scrutiny on credit products and debtor relief laws expanded. Cybersecurity and data privacy risk language shifted to model design and quantitative flaws.

Ames National Corp added trade policy risks regarding April 2025 tariffs and China retaliations, and artificial intelligence integration risks.

Added focus on the execution and short-term dilution of the new Consumer First Formula strategic transformation.

HeartBeam faces ongoing going concern doubts due to insufficient working capital to fund operations for the next twelve months.